RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Previous research has confirmed that hemorrhage is among the most commonly encountered pregnancy complications in the Tibet Autonomous Region (TAR). This trial will test the effectiveness of a traditional Tibetan drug (Zhi Byed 11) vs. misoprostol to prevent postpartum hemorrhage (PPH) among women delivering vaginally in three hospitals in Lhasa, TAR.
Epistemonikos ID: 434e18954c217530292964ecbe44b75ce649ba05
First added on: May 04, 2024